Adhesion to stromal cells mediates imatinib resistance in chronic myeloid leukemia through ERK and BMP signaling pathways
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-10373-3.pdf
Reference34 articles.
1. Druker, B. J. et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. New England Journal of Medicine 355, 2408–2417, doi: 10.1056/Nejmoa062867 (2006).
2. Maru, Y. Molecular biology of chronic myeloid leukemia. Cancer Science 103, 1601–1610, doi: 10.1111/j.1349-7006.2012.02346.x (2012).
3. Zhang, X. W., Subrahmanyam, R., Wong, R., Gross, A. W. & Ren, R. B. The NH2-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl. Molecular and Cellular Biology 21, 840–853, doi: 10.1128/Mcb.21.3.840-853.2001 (2001).
4. Puil, L. et al. Bcr-Abl Oncoproteins Bind Directly to Activators of the Ras Signaling Pathway. Embo Journal 13, 764–773 (1994).
5. Sattler, M. et al. Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 1, 479–492, doi: 10.1016/S1535-6108(02)00074-0 (2002).
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancing cellular insights: Super-resolution STORM imaging of cytoskeletal structures in human stem and cancer cells;Biochemistry and Biophysics Reports;2024-09
2. High-throughput formulation of reproducible 3D cancer microenvironments for drug testing in myelogenous leukemia;2024-01-12
3. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach;Cell Communication and Signaling;2023-11-29
4. Integrin Signaling Shaping BTK-Inhibitor Resistance;Cells;2022-07-18
5. Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia;Cancers;2022-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3